SIGA Declares Special Cash Dividend of $0.60 Per Share

Core Viewpoint - SIGA Technologies, Inc. announced a special cash dividend of $0.60 per share, marking the fourth consecutive year of such dividends, reflecting the company's strong balance sheet and confidence in future business prospects [1][2]. Company Overview - SIGA is a commercial-stage pharmaceutical company focused on developing innovative medicines for infectious diseases, particularly orthopoxviruses [2]. - The company's flagship product, TPOXX (tecovirimat), is an antiviral approved for treating smallpox and authorized for other related diseases in various regions including the U.S., Canada, Europe, the UK, and Japan [2]. Financial Management - The CEO emphasized the company's commitment to disciplined financial management and strategic execution to enhance long-term shareholder value [2].